Immix Biopharma, Inc

IMMXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

71.5M

on 2026-06-30, from 26.4M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$750.0M

S-3 of 2026-01-09. 2 prospectus supplements filed under it since. S-3 ↗

$100.0M

Citizens JMP Securities, agreement of 2026-03-25. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-07 is not read yet.

Cash

24.1 quarters

$232.1M on 2026-06-30 ÷ $9.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-09-29	Public offering	11,363,637	$11.00	$125.0M	424B5 ↗
2026-05-21	Public offering	16,778,524	$8.94	$150.0M	424B5 ↗
2025-12-07	Public offering incl. 0.49M pre-funded	19,607,842	$5.10	$100.0M	424B5 ↗
2025-09-05	Private placement	2,873,417	not read	$9.1M	8-K ↗